Get tips and insights from health-care professionals and people with diabetes, share your thoughts, and ask questions on our blog.
- Alternative Medicine/ Complementary Therapies
- Blood Glucose Monitoring
- Dental Health
- Diabetes News
- Diabetes Research
- Diabetic Complications
- Diagnosis
- Emotional Health
- Exercise
- Eyes & Vision
- Foot Care
- General Diabetes & Health Issues
- Heart Health
- High Blood Glucose
- Insulin & Other Injected Drugs
- Kids & Diabetes
- Living With Diabetes
- Low Blood Glucose
- Men's Health
- Money Matters
- Nutrition & Meal Planning
- Oral Medicines
- Sexual Health
- Tools & Technology
- Traveling With Diabetes
- Type 1 Diabetes
- Type 2 Diabetes
- Weight Loss
- What We're Reading
- Women's Health
Sign up for our weekly e-mail newsletter and receive a FREE GIFT! Enter your e-mail below.
Links to help you learn more about diabetes.
Ask a diabetes expert
Other diabetes resources
Browse article topics
Victoza Approved for Use. Should You Take It?
My plans for getting out of town are not going well this year. Because my friend Sandy works in the medical field, she takes continuing medical education (CME) courses here and there and I sometimes tag along…
New Drug Approved
On January 25, the US Food and Drug Administration (FDA) approved the injectable diabetes medicine liraglutide (brand name Victoza), developed by Novo Nordisk. Victoza is the first once-daily treatment in the class of drugs known as GLP-1 agonists. (Exenatide [Byetta] is the other member of the drug class.)
Insulin Effective and Accepted in Newly Diagnosed Type 2s
Insulin therapy is often resisted by people newly diagnosed with Type 2 diabetes because of fears of weight gain, low blood glucose (hypoglycemia), and a declining quality of life. But according to research recently published in the journal Diabetes Care, insulin-based treatment is safe, effective, and well tolerated in those newly diagnosed with Type 2 diabetes, and additionally it does not cause greater weight gain or more episodes of low blood glucose than oral diabetes treatments…
Diabetes Drugs: Pramlintide
Many people do not think of the brain when considering the causes of or treatments for diabetes. So it may be surprising to learn that the drug we are discussing today works by activating brain cells…
Oral Insulin Conditionally Approved by FDA
The U.S. Food and Drug Administration (FDA) has approved Oral-lyn, an insulin spray for people with Type 1 and Type 2 diabetes, for its Treatment Investigational New Drug (IND) program. This approval will allow Generex Biotechnology Corporation, developers of Oral-lyn, to provide early access to the medicine to people with serious or life-threatening Type 1 or Type 2 diabetes who have no satisfactory alternative treatments and who are not eligible for participation in the company’s ongoing Phase III clinical trial of the drug…
Diabetes Drugs: GLP-1 Agonists
A curious fact that has been known almost since the discovery of insulin is that glucose taken by mouth stimulates insulin secretion to a greater degree than glucose that is injected straight into the bloodstream. Researchers theorized that a hormone might be released by the gastrointestinal tract in response to glucose that was able to stimulate insulin secretion above and beyond that stimulated by glucose alone. This then-undiscovered hormone was called “incretin,” since it seemed to stimulate insulin production…
Disclaimer of Medical Advice: You understand that the blog posts and comments to such blog posts (whether posted by us, our agents or bloggers, or by users) do not constitute medical advice or recommendation of any kind, and you should not rely on any information contained in such posts or comments to replace consultations with your qualified health care professionals to meet your individual needs. The opinions and other information contained in the blog posts and comments do not reflect the opinions or positions of the Site Proprietor.
